Hosted by Komodo Health

From the earliest days of the COVID-19 vaccine rollout this winter, one immediate challenge became apparent: inequity in distribution. When it comes to COVID-19, Black, Latino and Native Americans (many of whom are also frontline workers) have higher rates of infection, hospitalization and death than their relative proportion of the population. At the same time, these same populations are being vaccinated against the virus at lower rates. Leading experts will share why and where certain communities are underserved, how to combat vaccine skepticism and how we can best use lessons from our healthcare history to achieve more equitable vaccination efforts going forward.

Hosted by Salesforce

As vaccines roll out and water cooler chatter hums about a “return to normal,” we’re likely to see a new phenomenon take place: a hybrid workforce that blends remote colleagues with those working side-by-side. For companies large and small, this will require introducing some new and adaptive ways of collaborating, idea-generating, and boosting morale. In this conversation  we take these challenges—from reskilling to workplace safety to onboarding new employees and ultimately, to building a mentally and emotionally resilient workforce—head on. A discussion on how creativity and innovation can support this once-in-a-lifetime workplace pivot.

For decades, disparities in care have plagued our health care system and the COVID-19 pandemic thrust these divisions under a national spotlight. For underserved communities, there’s still much work to be done when it comes to the affordability of and access to care. A conversation with the CEO of the nation’s largest integrated health system, Greg Adams and Intermountain Health CEO Dr. Marc Harrison will address how the industry can improve community health and affect change at a systematic level.

Motivated by frustration and helplessness with the nation’s health care system in her own childhood loss, Karen S. Lynch built her career around fixing a broken system. She took the helm at one of the world’s largest healthcare companies just this year after leading the CVS Health COVID-19 response from the start of the pandemic. Now she’s set her sights on improving access to affordable health care while transitioning the business to a broader health services company.

The cascading crises of the past year have tested both the resiliency of the health care system and its social conscience. Gilead CEO Daniel O’Day joins us to discuss how his company pivoted and ushered through the approval of remdesivir, an antiviral now being used by roughly half of hospitalized coronavirus patients. We’ll also look beyond COVID-19, as Gilead continues the fight against cancer and HIV—with new treatments in the pipeline—and ongoing efforts to tackle racial and social justice.

After a year of lightning fast vaccine development and rollout, there’s even more hope on the horizon. Pfizer and BioNTech recently reported their COVID-19 vaccine to be 100 percent effective for teens aged 12 to 15, raising the possibility for a full-time return to school for more of this nation’s children. In this 1-on-1, Pfizer CEO Dr. Albert Bourla shares how his company survived a year of immense change and pressure, how science won the day and what this race to the finish means to him.

As the entire world faces off against an insidious globetrotting virus, our focus has drifted away from the chronic, non-communicable health issues that affect millions of people and cost untold billions of dollars a year to treat. From cancer to diabetes to depression, a quiet shadow epidemic of disease is looming. Yes, we are all anxious to put COVID-19 in the rearview mirror. But here’s what we must consider when it comes to treating, or hopefully preventing, the pathologies that await us on the road ahead.

Let us state an uncomfortable fact: every patient journey is an unwanted one. But how can we make that experience less agonizing, less confusing, and less traumatic? How do we transform from within to make sure that journey is at least headed to the right destination—with fewer detours, delays, and disappointments along the way?

What to teach a new generation of public health officials to help us prevent the next pandemic—or at least thrive better in it.

COVID-19 sent the restaurant industry into an unprecedented decline, but the CEO of the Union Square Hospitality Group, Danny Meyer, isn’t giving up on eating out. He’s keeping his teams motivated, making safety the new ambience, and taking his “culture-first” philosophy beyond the hospitality industry. Here’s what resilience looks like in the post-pandemic era.

The global COVID-19 pandemic has tested leadership like few other events in recent history. CEOs, elected officials, and top brass everywhere have found themselves at a turning point: The most successful ones understand how to drive the mission toward the organization’s purpose while making every stakeholder feel a part of it. We are joined by two powerful guides in this quest—one from business and the other from the military.

The U.S. has four percent of the world’s population, but an overwhelming surplus of world vaccine supply locked up. Meanwhile the rest of the world—despite valiant and creative effort through the COVAX Facility to create a plan for global distribution—is struggling to get enough vaccine for billions of people. How can the world come together in this most urgent of tasks?

Quantum computing may offer us a revolutionary opportunity to solve the most intractable problems in healthcare. Tapping into the mysterious power of the atom may one day help us achieve pinpoint diagnoses, discover new drugs with breakneck speed, and even solve some of the biggest puzzles of healthcare economics.

Oscar Munoz knows a lot about bouncing back. When the vegan triathlete required a heart transplant shortly after taking the reins at United, it was a shock to the system. After his own recovery, he turned around what had been a struggling and divided airline. Now, with the COVID-19 pandemic having grounded flights on an unprecedented global scale and the travel industry facing uncertainty about when business will return, he is applying the same resilience to the future of his industry.